Your browser doesn't support javascript.
loading
Anthracycline, Gemcitabine, and Pazopanib in Epithelioid Sarcoma: A Multi-institutional Case Series.
Frezza, Anna Maria; Jones, Robin L; Lo Vullo, Salvatore; Asano, Naofumi; Lucibello, Francesca; Ben-Ami, Eytan; Ratan, Ravin; Teterycz, Pawel; Boye, Kjetil; Brahmi, Mehdi; Palmerini, Emanuela; Fedenko, Alexander; Vincenzi, Bruno; Brunello, Antonella; Desar, Ingrid M E; Benjamin, Robert S; Blay, Jean Yves; Broto, Javier Martin; Casali, Paolo G; Gelderblom, Hans; Grignani, Giovanni; Gronchi, Alessandro; Hall, Kirsten Sundby; Mir, Olivier; Rutkowski, Piotr; Wagner, Andrew J; Anurova, Olga; Collini, Paola; Dei Tos, Angelo P; Flucke, Uta; Hornick, Jason L; Lobmaier, Ingvild; Philippe, Terrier; Picci, Piero; Ranchere, Dominique; Renne, Salvatore L; Sbaraglia, Marta; Thway, Khin; Wagrodzki, Michal; Wang, Wei-Lien; Yoshida, Akihiko; Mariani, Luigi; Kawai, Akira; Stacchiotti, Silvia.
Afiliación
  • Frezza AM; Department of Medical Oncology, IRCCS Fondazione Istituto Nazionale Tumori, Milano, Italy.
  • Jones RL; Sarcoma Unit, Royal Marsden NHS Foundation Trust/ Institute of Cancer Research, Chelsea, London, United Kingdom.
  • Lo Vullo S; Unit of Clinical Epidemiology and Trial Organization, IRCCS Fondazione Istituto Nazionale Tumori, Milano, Italy.
  • Asano N; Department of Musculoskeletal Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Lucibello F; Department of Cancer Medicine, Gustave Roussy Cancer Campus, Villejuif, France.
  • Ben-Ami E; Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Ratan R; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston.
  • Teterycz P; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Institute-Oncology Center, Warsaw, Poland.
  • Boye K; Department of Oncology, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.
  • Brahmi M; Department of Medical Oncology, Centre Léon Bérard & Université Claude Bernard Lyon I, Lyon, France.
  • Palmerini E; Department of Cancer Medicine, Istituto Ortopedico Rizzoli, Bologna, Italy.
  • Fedenko A; Department of Medical Oncology, N.N. Blokhin Russian Cancer Research, Moscow, Russian Federation.
  • Vincenzi B; Department of Medical Oncology, Università Campus Bio-Medico di Roma, Roma, Italy.
  • Brunello A; Department of Clinical and Experimental Oncology, Medical Oncology 1 Unit, Istituto Oncologico Veneto IOV-IRCCS, Padova, Italy.
  • Desar IME; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Benjamin RS; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston.
  • Blay JY; Department of Medical Oncology, Centre Léon Bérard & Université Claude Bernard Lyon I, Lyon, France.
  • Broto JM; Department of Medical Oncology, University Hospital Virgen del Rocio and LAB 215 IBIS, Sevilla, Spain.
  • Casali PG; Department of Medical Oncology, IRCCS Fondazione Istituto Nazionale Tumori, Milano, Italy.
  • Gelderblom H; University of Milan, Department of Oncology and Hemato-oncology, Milan, Italy.
  • Grignani G; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands.
  • Gronchi A; Sarcoma Unit, Division of Medical Oncology Candiolo Cancer Institute, FPO, IRCCS Candiolo, Torino, Italy.
  • Hall KS; Sarcoma Surgery, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy.
  • Mir O; Department of Oncology, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.
  • Rutkowski P; Department of Cancer Medicine, Gustave Roussy Cancer Campus, Villejuif, France.
  • Wagner AJ; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Institute-Oncology Center, Warsaw, Poland.
  • Anurova O; Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Collini P; Department of Pathology, N.N. Blokhin Russian Cancer Research, Moscow, Russian Federation.
  • Dei Tos AP; Department of Diagnostic Pathology and Laboratory Medicine, IRCCS Fondazione Istituto Nazionale dei Tumori, Milan, Italy.
  • Flucke U; Department of Pathology, Treviso Regional Hospital, Treviso, Italy.
  • Hornick JL; Department of Medicine, University of Padua, Padova, Italy.
  • Lobmaier I; Department of Pathology, Radboud University Medical Centre, Nijmegen, the Netherlands.
  • Philippe T; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
  • Picci P; Department of Pathology, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.
  • Ranchere D; Department of Pathology, Gustave Roussy Cancer Campus, Villejuif, France.
  • Renne SL; Department of Pathology, Istituto Ortopedico Rizzoli, Bologna, Italy.
  • Sbaraglia M; Department of Pathology, Centre Léon Bérard & Université Claude Bernard Lyon I, Lyon, France.
  • Thway K; Department of Diagnostic Pathology and Laboratory Medicine, IRCCS Fondazione Istituto Nazionale dei Tumori, Milan, Italy.
  • Wagrodzki M; Department of Pathology, Treviso Regional Hospital, Treviso, Italy.
  • Wang WL; Sarcoma Unit, Royal Marsden NHS Foundation Trust/ Institute of Cancer Research, Chelsea, London, United Kingdom.
  • Yoshida A; Department of Pathology, Maria Sklodowska-Curie Institute-Oncology Center, Warsaw, Poland.
  • Mariani L; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston.
  • Kawai A; Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan.
  • Stacchiotti S; Unit of Clinical Epidemiology and Trial Organization, IRCCS Fondazione Istituto Nazionale Tumori, Milano, Italy.
JAMA Oncol ; 4(9): e180219, 2018 09 01.
Article en En | MEDLINE | ID: mdl-29800950
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Sarcoma / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Guideline / Observational_studies / Risk_factors_studies Idioma: En Revista: JAMA Oncol Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Sarcoma / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Guideline / Observational_studies / Risk_factors_studies Idioma: En Revista: JAMA Oncol Año: 2018 Tipo del documento: Article